Medicalgorithmics SA stock news
Medicalgorithmics SA has entered into a strategic commercial partnership with React Health, a prominent US--based provider of medical devices and diagnostic services. The agreement facilitates the integration of Medicalgorithmics' proprietary AI--powered ECG analysis technology, specifically the DeepRhythm Platform, into React Health's cardiac monitoring portfolio. This collaboration is a key component of the company's expansion strategy in the North American market and is expected to generate new recurring revenue streams starting in the third quarter of 2026, supporting the company's transition toward a software--as--a--service (SaaS) business model.